Literature DB >> 10753840

Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation.

M B Sobocka1, T Sobocki, P Banerjee, C Weiss, J I Rushbrook, A J Norin, J Hartwig, M O Salifu, M S Markell, A Babinska, Y H Ehrlich, E Kornecki.   

Abstract

This study demonstrates that the human platelet F11 receptor (F11R) functions as an adhesion molecule, and this finding is confirmed by the structure of the protein as revealed by molecular cloning. The F11R is a 32-/35-kd protein duplex that serves as the binding site through which a stimulatory monoclonal antibody causes platelet aggregation and granule secretion. A physiological role for the F11R protein was demonstrated by its phosphorylation after the stimulation of platelets by thrombin and collagen. A pathophysiological role for the F11R was revealed by demonstrating the presence of F11R-antibodies in patients with thrombocytopenia. Adhesion of platelets through the F11R resulted in events characteristic of the action of cell adhesion molecules (CAMs). To determine the structure of this protein, we cloned the F11R cDNA from human platelets. The predicted amino acid sequence demonstrated that it is an integral membrane protein and an immunoglobulin superfamily member containing 2 extracellular C2-type domains. The structure of the F11R as a member of a CAM family of proteins and its activity in mediating adhesion confirm each another. We conclude that the F11R is a platelet-membrane protein involved in 2 distinct processes initiated on the platelet surface. The first is antibody-induced platelet aggregation and secretion that are dependent on both the FcgammaRII and the GPIIb/IIIa integrin and that may be involved in pathophysiological processes associated with certain thrombocytopenias. The second is an F11R-mediated platelet adhesion that is not dependent on either the FcgammaRII or the fibrinogen receptor and that appears to play a role in physiological processes associated with platelet adhesion and aggregation. (Blood. 2000;95:2600-2609)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753840

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration.

Authors:  Ke Zen; Brian A Babbin; Yuan Liu; John B Whelan; Asma Nusrat; Charles A Parkos
Journal:  Mol Biol Cell       Date:  2004-06-11       Impact factor: 4.138

2.  JAM-A protects from thrombosis by suppressing integrin αIIbβ3-dependent outside-in signaling in platelets.

Authors:  Meghna U Naik; Timothy J Stalker; Lawrence F Brass; Ulhas P Naik
Journal:  Blood       Date:  2012-01-23       Impact factor: 22.113

Review 3.  Mechanisms of reovirus bloodstream dissemination.

Authors:  Karl W Boehme; Caroline M Lai; Terence S Dermody
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

4.  Endothelial JAM-A promotes reovirus viremia and bloodstream dissemination.

Authors:  Caroline M Lai; Karl W Boehme; Andrea J Pruijssers; Vrajesh V Parekh; Luc Van Kaer; Charles A Parkos; Terence S Dermody
Journal:  J Infect Dis       Date:  2014-08-22       Impact factor: 5.226

5.  Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma Does not reduce leukocyte transmigration under flow.

Authors:  S K Shaw; B N Perkins; Y C Lim; Y Liu; A Nusrat; F J Schnell; C A Parkos; F W Luscinskas
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

6.  Cis-dimerization mediates function of junctional adhesion molecule A.

Authors:  Eric A Severson; Liangyong Jiang; Andrei I Ivanov; Kenneth J Mandell; Asma Nusrat; Charles A Parkos
Journal:  Mol Biol Cell       Date:  2008-02-13       Impact factor: 4.138

7.  A comparative molecular force spectroscopy study of homophilic JAM-A interactions and JAM-A interactions with reovirus attachment protein sigma1.

Authors:  Sri Ram Krishna Vedula; Tong Seng Lim; Eva Kirchner; Kristen M Guglielmi; Terence S Dermody; Thilo Stehle; Walter Hunziker; Chwee Teck Lim
Journal:  J Mol Recognit       Date:  2008 Jul-Aug       Impact factor: 2.137

Review 8.  Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis.

Authors:  Astrid O Leech; Rodrigo G B Cruz; Arnold D K Hill; Ann M Hopkins
Journal:  Ann Transl Med       Date:  2015-08

Review 9.  Mechanisms of neutrophil transendothelial migration.

Authors:  Eun Young Choi; Sentot Santoso; Triantafyllos Chavakis
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

Review 10.  Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell-Cell Interactions in Tumor Progression.

Authors:  Adam Lauko; Zhaomei Mu; Ulhas P Naik; Justin D Lathia; David H Gutmann
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.